Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2019/01/017202
CTRI/2019/01/017202
Completed
Phase 2

Comparative study of the safety and therapeutic efficacy of oral cyclosporine and oral betamethasone minipulse therapy in the treatment of alopecia areata.

Shibashis Chatterjee0 sites60 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: L639- Alopecia areata, unspecified

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: L639- Alopecia areata, unspecified
Sponsor
Shibashis Chatterjee
Enrollment
60
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 30, 2020
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Shibashis Chatterjee

Eligibility Criteria

Inclusion Criteria

  • •1\.Patients consenting for the study.
  • •2\.All the patients presenting with circumscribed patch of hair loss without any signs of inflammation or scarring,of size \> 3cm in diameter.
  • •3\.Patients who have symptoms of 3 months or more duration.
  • •4\.Patients who have not taken any other modalities of treatment in the last 3 months.

Exclusion Criteria

  • •1\.Patients who are k/c/o hypertension.
  • •2\.Patients with secondary infection.
  • •3\.Pregnant and lactating females.
  • •4\.Patients with pre\-existing renal and liver diseases.
  • •5\.Patients with diabetes mellitus.
  • •6\.Patients having any Autoimmune disease like SLE, Sjogrenâ??s Syndrome,etc.
  • •7\.Patients having contraindications to the drugs used in the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Effect of 10% Potassium hydroxide and 50% Trichloroacetic acid on plane warts
IRCT20170829035976N2Ahvaz University of Medical Sciences64
Recruiting
Phase 4
Comparative study of efficacy, safety and patient compliance of Dapagliflozin(anti diabetic drug) and Metformin(anti diabetic drug) Vs Vildagliptin(anti diabetic drug) and Metformin combination therapy in newly diagnosed Type 2 diabetes patients
CTRI/2020/12/030147Kumar Gautam
Not yet recruiting
Not Applicable
Comparing two fluorescein dyes in subjects undergoing dry eye evaluation for pre-refractive surgery workupHealth Condition 1: H048- Other disorders of lacrimal system
CTRI/2021/11/038197BioTech Vision Care Pvt Ltd
Completed
Not Applicable
Comparative clinical trial of domestic and foreign fillers
KCT0008324Pusan National University Hospital100
Recruiting
Not Applicable
Comparative Therapeutic Effectiveness and Safety of Locally Compounded, and some over the Counter Topical Analgesics in the Management of Neuropathic
PACTR201711002652161Department of Pharmaceutical Services, NASS Clinic32